Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-15-001313
Filing Date
2015-05-15
Accepted
2015-05-15 16:15:57
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q biostarpharma10q033115.htm 10-Q 939215
2 EX-31.1 ex31-1.htm EX-31.1 14421
3 EX-31.2 ex31-2.htm EX-31.2 14247
4 EX-32.1 ex32-1.htm EX-32.1 5785
5 EX-32.2 ex32-2.htm EX-32.2 5592
  Complete submission text file 0001185185-15-001313.txt   7817664

Data Files

Seq Description Document Type Size
6 EX-101.INS bspm-20150331.xml EX-101.INS 1458453
7 EX-101.SCH bspm-20150331.xsd EX-101.SCH 53087
8 EX-101.CAL bspm-20150331_cal.xml EX-101.CAL 41281
9 EX-101.DEF bspm-20150331_def.xml EX-101.DEF 252525
10 EX-101.LAB bspm-20150331_lab.xml EX-101.LAB 307127
11 EX-101.PRE bspm-20150331_pre.xml EX-101.PRE 255150
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 15869650
SIC: 2834 Pharmaceutical Preparations